A Glimpse of Vir Biotechnology's Earnings Potential

Vir Biotechnology (NASDAQ:VIR) is gearing up to announce its quarterly earnings on Monday, 2026-02-23. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Vir Biotechnology will report an earnings per share (EPS) of $-0.47.

Investors in Vir Biotechnology are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings Track Record

During the last quarter, the company reported an EPS missed by $0.37, leading to a 5.19% drop in the share price on the subsequent day.

Here's a look at Vir Biotechnology's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.80	-0.72	-0.84	-0.87
EPS Actual	-1.17	-0.80	-0.88	-0.76
Price Change %	-5.00	-14.00	-4.00	-12.00

Performance of Vir Biotechnology Shares

Shares of Vir Biotechnology were trading at $7.82 as of February 19. Over the last 52-week period, shares are down 19.48%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for Vir Biotechnology visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.